Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ICU | US
0.50
13.48%
Healthcare
Biotechnology
30/06/2024
13/04/2026
4.21
3.71
4.28
3.70
SeaStar Medical Holding Corporation a medical device company develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver Colorado.
View LessLow Debt to Equity (< 0.25)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
213.2%1 month
174.8%3 months
124.5%6 months
113.4%-
-
-
-0.46
0.91
-8.13
-
-
-
17.65M
17.65M
-
-
-
-
-
3.59
5.29
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.19
Range1M
2.86
Range3M
2.86
Rel. volume
0.29
Price X volume
325.13K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Edesa Biotech Inc | EDSA | Biotechnology | 5.9 | 19.16M | 6.88% | n/a | 1.35% |
| DOMH | DOMH | Biotechnology | 3 | 18.83M | 4.17% | n/a | 7.66% |
| PLUR | PLUR | Biotechnology | 3.3407 | 18.27M | 0.62% | n/a | 30845.83% |
| Enlivex Therapeutics Ltd | ENLV | Biotechnology | 0.8382 | 17.94M | -12.82% | n/a | 2.92% |
| Can-Fite BioPharma Ltd | CANF | Biotechnology | 2.92 | 17.80M | 0.00% | n/a | 0.00% |
| Enveric Biosciences Inc | ENVB | Biotechnology | 1.97 | 17.57M | 0.36% | n/a | 0.00% |
| Inhibikase Therapeutics Inc. | IKT | Biotechnology | 1.71 | 17.06M | 0.59% | n/a | 3.49% |
| Cingulate Inc. Common Stock | CING | Biotechnology | 5.5 | 16.74M | -4.51% | n/a | 10.72% |
| Aytu BioScience Inc | AYTU | Biotechnology | 2.63 | 16.17M | 3.14% | n/a | 54.59% |
| Longeveron Inc. Class A Common Stock | LGVN | Biotechnology | 1.12 | 16.08M | -3.45% | n/a | 11.72% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 10.4 | 15.84M | -11.56% | n/a | 204.46% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.8799 | 12.86M | -18.53% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.6 | 11.59M | -0.17% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.33 | 3.40M | -0.75% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2276 | 2.17M | -10.25% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.07 | 1.14M | -0.96% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.13 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 124.51 | 72.80 | Riskier |
| Debt to Equity | -0.46 | -1.23 | Expensive |
| Debt to Assets | 0.91 | 0.25 | Expensive |
| Market Cap | 17.65M | 3.66B | Emerging |